Personalized Autologous Transplant for Multiple Myeloma

NCT04483206 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
DRUG: Melphalan
OTHER: Questionnaire Administration

Sponsor

Emory University

Collaborators

[object Object]
[object Object]